GlobeNewsWire
20 Aug 2026, 18:50 UTC · 1h ago
Bragar Eagel & Squire, P.C. is Investigating Alnylam Pharmaceuticals, Inc. on Behalf of Alnylam Stockholders and Encourages Investors to Contact the Firm
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.






